Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Alirocumab for arterial wall inflammation in statin-intolerant high cardiovascular risk patients
NL-OMON45376Phase 2Active, not recruiting
- Sponsor
- Amsterdam University Medical Center
- Start
- Apr 2017
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2 trial of alirocumab in atherosclerosis and hypercholesterolemia (2 arms), sponsored by Amsterdam University Medical Center. Started Apr 2017; status: active, not recruiting.
02
Drugs
alirocumab
03
Conditions
atherosclerosishypercholesterolemia
Beyond the preview
Go deeper on NL-OMON45376.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON45376.